Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
African Journal of Laboratory Medicine
| Field | Value | |
| Title | Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa | |
| Creator | Cassim, Naseem Coetzee, Lindi M. Makuraj, Abel L. Stevens, Wendy S. Glencross, Deborah K. | |
| Description | Background: Globally, tuberculosis remains a major cause of mortality, with an estimated 1.3 million deaths per annum. The Xpert MTB/RIF assay is used as the initial diagnostic test in the tuberculosis diagnostic algorithm. To extend the national tuberculosis testing programme in South Africa, mobile units fitted with the GeneXpert equipment were introduced to high-burden peri-mining communities.Objective: This study sought to assess the cost of mobile testing compared to traditional laboratory-based testing in a peri-mining community setting.Methods: Actual cost data for mobile and laboratory-based Xpert MTB/RIF testing from 2018 were analysed using a bottom-up ingredients-based approach to establish the annual equivalent cost and the cost per result. Historical cost data were obtained from supplier quotations and the local enterprise resource planning system. Costs were obtained in rand and reported in United States dollars (USD).Results: The mobile units performed 4866 tests with an overall cost per result of $49.16. Staffing accounted for 30.7% of this cost, while reagents and laboratory equipment accounted for 20.7% and 20.8%. The cost per result of traditional laboratory-based testing was $15.44 US dollars (USD). The cost for identifying a tuberculosis-positive result using mobile testing was $439.58 USD per case, compared to $164.95 USD with laboratory-based testing.Conclusion: Mobile testing is substantially more expensive than traditional laboratory services but offers benefits for rapid tuberculosis case detection and same-day antiretroviral therapy initiation. Mobile tuberculosis testing should however be reserved for high-burden communities with limited access to laboratory testing where immediate intervention can benefit patient outcomes. | |
| Publisher | AOSIS | |
| Date | 2021-11-30 | |
| Identifier | 10.4102/ajlm.v10i1.1229 | |
| Source | African Journal of Laboratory Medicine; Vol 10, No 1 (2021); 7 pages 2225-2010 2225-2002 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://ajlmonline.org/index.php/ajlm/article/view/1229/2076
https://ajlmonline.org/index.php/ajlm/article/view/1229/2077
https://ajlmonline.org/index.php/ajlm/article/view/1229/2078
https://ajlmonline.org/index.php/ajlm/article/view/1229/2079
|
|
ADVERTISEMENT
